AlphaCentric Advisors LLC — 13F Holdings & Portfolio

CIK 1913464 · latest 13F-HR filed 2026-11-03

AlphaCentric Advisors LLC manages $112.6M in 13F-reported U.S. long-equity assets across 247 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are SHY (4.76%), GILD (2.82%), IWD (2.65%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 34 new positions and exited 48; 85 existing positions rose in reported value and 94 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$112.6M

Long-equity book

Holdings
247

Distinct positions

Period
2026-09-30

Filed 2026-11-03

Q/Q Activity
+34 / −48 / ↑85 / ↓94

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 23.4%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Jun 2, 2026.

Assets Under Management
$433.1M
Discretionary
$433.1M
Employees
11
Accounts
6
Address
207 CALLE DEL PARQUE
FLOOR 7, SUITE 2
SAN JUAN, PR 00912
Phone
(646) 757-8387
This firm reports 4 disclosure items on its registration.
Name Title / Status Ownership Type
ALPHA PARTNERS LLC ControlMEMBER
since Apr 2014
25–50%Domestic Entity
GLASS, ROBERT, DAVID ControlCCO
since Feb 2015
Less than 5%Individual
SZILAGYI, JERRY, JOHN ControlMANAGING MEMBER
since Apr 2014
25–50%Individual
Schoonover, Michael, Thomas ControlMEMBER
since Jun 2026
5–10%Individual
JERRY J. SZILAGYI 2015 FAMILY TRUSTMEMBER
since Dec 2015
10–25%Domestic Entity
MILLER, DAVID, SCOTT Control
Indirect owner via ALPHA PARTNERS LLC
MEMBER
since Jun 2026
25–50%Individual
SZILAGYI, ISOBEL, LINDA
Indirect owner via JERRY J. SZILAGYI 2015 FAMILY TRUST
TRUSTEE
since Dec 2015
General partner, trustee or managerIndividual
Szilagyi, June, Ann
Indirect owner via JERRY J. SZILAGYI 2015 FAMILY TRUST
TRUSTEE
since Dec 2015
General partner, trustee or managerIndividual
Ownership & leadership changes · 8 filings with changes since Apr 9, 2014

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Jun 2, 2026 filing
  • No longer listedKAMIES, MARK, JAMES · MEMBER · 5–10% · control person · listed since Apr 2014
  • AddedMILLER, DAVID, SCOTT · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC · control person
  • AddedSchoonover, Michael, Thomas · MEMBER · 5–10% · control person
Mar 27, 2024 filing
  • No longer listedBETTER OUTCOMES LLC · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC · listed since Feb 2022
Jul 13, 2022 filing
  • ChangedGLASS, ROBERT, DAVID · now a control person
Apr 12, 2022 filing
  • AddedBETTER OUTCOMES LLC · MEMBER · 25–50% · indirect via ALPHA PARTNERS LLC
Mar 29, 2022 filing
  • ChangedKAMIES, MARK, JAMES · title MANAGING MEMBER → MEMBER
Mar 23, 2018 filing
  • AddedSZILAGYI, ISOBEL, LINDA · TRUSTEE · General partner, trustee or manager · indirect via JERRY J. SZILAGYI 2015 FAMILY TRUST
  • AddedSzilagyi, June, Ann · TRUSTEE · General partner, trustee or manager · indirect via JERRY J. SZILAGYI 2015 FAMILY TRUST
  • ChangedJERRY J. SZILAGYI 2015 FAMILY TRUST · title SHAREHOLDER → MEMBER
Mar 29, 2016 filing
  • AddedJERRY J. SZILAGYI 2015 FAMILY TRUST · SHAREHOLDER · 10–25%
  • ChangedSZILAGYI, JERRY, JOHN · ownership 50–75% → 25–50%
Feb 18, 2015 filing
  • AddedGLASS, ROBERT, DAVID · CCO · Less than 5%
  • ChangedKAMIES, MARK, JAMES · now a control person
  • ChangedSZILAGYI, JERRY, JOHN · title MANAGING MEMBER AND CCO → MANAGING MEMBER
Apr 9, 2014 filing (earliest on record)
  • ListedALPHA PARTNERS LLC · MEMBER · 25–50% · control person
  • ListedKAMIES, MARK, JAMES · MANAGING MEMBER · 5–10%
  • ListedSZILAGYI, JERRY, JOHN · MANAGING MEMBER AND CCO · 50–75% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

AlphaCentric Advisors LLC Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ISHARES TR SHY 464287457 $5.4M 4.76% 66,011 SH
2 GILEAD SCIENCES INC GILD 375558103 $3.2M 2.82% 21,278 SH
3 ISHARES TR IWD 464287598 $3.0M 2.65% 12,020 SH
4 INVESCO EXCHANGE TRADED FD T RPV 46137V258 $2.9M 2.59% 25,447 SH
5 VERTEX PHARMACEUTICALS INC VRTX 92532F100 $2.7M 2.37% 5,115 SH
6 INVITATION HOMES INC INVH 46187W107 $1.9M 1.71% 73,000 SH
7 ASTRAZENECA PLC AZN G0593M107 $1.9M 1.70% 11,866 SH
8 ROIVANT SCIENCES LTD ROIV G76279101 $1.8M 1.64% 50,535 SH
9 INCYTE CORP INCY 45337C102 $1.8M 1.63% 15,140 SH
10 ARGENX SE ARGX 04016X101 $1.8M 1.57% 1,841 SH
11 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $1.5M 1.29% 10,230 SH
12 EURONET WORLDWIDE INC EEFT 298736109 $1.4M 1.20% 21,560 SH
13 PROTAGONIST THERAPEUTICS INC PTGX 74366E102 $1.4M 1.20% 9,616 SH
14 INSMED INC INSM 457669307 $1.4M 1.20% 11,866 SH
15 ALPINE INCOME PPTY TR INC PINE 02083X103 $1.3M 1.16% 75,000 SH
16 BUILDERS FIRSTSOURCE INC BLDR 12008R107 $1.3M 1.14% 22,500 SH
17 AXSOME THERAPEUTICS INC. AXSM 05464T104 $1.2M 1.11% 6,752 SH
18 JAZZ PHARMACEUTICALS PLC JAZZ G50871105 $1.1M 0.96% 4,688 SH
19 HALOZYME THERAPEUTICS INC HALO 40637H109 $1.1M 0.96% 9,821 SH
20 ASCENDIS PHARMA A/S ASND K08588103 $1.1M 0.95% 4,706 SH
21 AMGEN INC AMGN 031162100 $1.0M 0.92% 2,455 SH
22 CTO RLTY GROWTH INC NEW CTO 22948Q101 $1.0M 0.91% 50,000 SH
23 UNUSUAL MACHS INC UMAC 91532F102 $979.2K 0.87% 40,000 SH
24 ABBVIE INC ABBV 00287Y109 $963.4K 0.86% 3,683 SH
25 ISHARES TR IYR 464287739 $950.4K 0.84% 10,000 SH
26 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $935.1K 0.83% 9,821 SH
27 BIOGEN INC BIIB 09062X103 $924.3K 0.82% 4,092 SH
28 PERSONALIS INC PSNL 71535D106 $909.3K 0.81% 55,854 SH
29 SAUL CTRS INC BFS 804395101 $902.4K 0.80% 30,000 SH
30 PENNANTPARK INVTS CORP PNNT 708062104 $891.0K 0.79% 270,000 SH
31 ROCKWELL AUTOMATION INC ROK 773903109 $870.7K 0.77% 2,000 SH
32 TEMPUS AI INC TEM 88023B103 $819.0K 0.73% 10,000 SH
33 CENTERSPACE CSR 15202L107 $816.0K 0.72% 15,000 SH
34 J P MORGAN EXCHANGE TRADED F BBJP 46641Q217 $780.5K 0.69% 9,943 SH
35 XOMETRY INC XMTR 98423F109 $771.4K 0.68% 7,500 SH
36 ASML HLDG NV ASML N07059210 $770.0K 0.68% 425 SH
37 GLOBUS MED INC GMED 379577208 $749.0K 0.67% 10,000 SH
38 STEREOTAXIS INC STXS 85916J409 $738.0K 0.66% 600,000 SH
39 SYMBOTIC INC SYM 87151X101 $736.2K 0.65% 17,500 SH
40 ISHARES INC EWA 464286103 $725.4K 0.64% 25,625 SH
41 IONIS PHARMACEUTICALS INC IONS 462222100 $721.7K 0.64% 16,163 SH
42 INTUITIVE SURGICAL INC ISRG 46120E602 $711.6K 0.63% 1,750 SH
43 AEROVIRONMENT INC AVAV 008073108 $711.1K 0.63% 5,000 SH
44 MANHATTAN ASSOCIATES INC MANH 562750109 $695.5K 0.62% 3,500 SH
45 KRYSTAL BIOTECH INC KRYS 501147102 $680.4K 0.60% 2,046 SH
46 REDWIRE CORPORATION RDW 75776W103 $678.6K 0.60% 65,000 SH
47 EDGEWISE THERAPEUTICS INC EWTX 28036F105 $672.8K 0.60% 16,572 SH
48 ONDAS INC ONDS 68236H204 $659.7K 0.59% 90,000 SH
49 SYNOPSYS INC SNPS 871607107 $652.4K 0.58% 1,500 SH
50 BIONTECH SE BNTX 09075V102 $643.6K 0.57% 6,547 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-03 $112.6M 247 0001580642-26-007378
2026-06-30 2026-07-24 $118.0M 261 0001580642-26-004575
2026-03-31 2026-05-07 $100.1M 252 0001580642-26-003040
2025-12-31 2026-02-12 $100.3M 250 0001580642-26-001010
Filer Information
Address
207 CALLE DE PARQUE ST.
SAN JUAN 00912
Phone
(631) 629-4907
Filing Manager
AlphaCentric Advisors LLC
SAN JUAN, PR
Signatory
Robert Glass
Chief Compliance Officer